The APAC Platelet Aggregation Devices Market was valued at USD 47.49 million in 2022, to grow at a CAGR of 26.3%, to reach USD 152.62 million by 2027 during the forecast period 2022 to 2027.
The increase in the rise of burden of chronic illnesses as well as the growing elderly population in this region with the issues like Heart issues, such as stroke and coronary heart disease, are becoming more common, resulting in the burden of cardiac mortality, which has fueled the expansion of the platelet aggregation devices market it is due to the continuous change in the lifestyle. Therefore, the platelet aggregation systems used to identify bleeding disorders are likely to increase demand as the prevalence of bleeding diseases rises.
An increase in the technical developments and advancements in the platelet aggregometer contribute to the growth of the platelet aggregation devices market. As it includes, the most effective approach for detecting platelet abnormalities is by the light transmission aggregometry.
Furthermore, light transmission aggregometry requires a large sample volume, and analytical variables influence the results. Also, aggregometry techniques have been developed and advanced due to these factors in traditional aggregometry and are now widely utilized in the market. Therefore, these advances have been proven to improve acceptance rates and aid market expansion and growth.
Platelet aggregation systems are in high demand in academic and pharmaceutical companies due to increased research studies, primarily to understand the mechanisms involved in platelet interaction with vascular surfaces and to evaluate and screen anti-thrombotic factors to identify new targets for antiplatelet drugs.
An increase in the average costs of the devices worldwide restricts the market growth. In addition, the lack of skilled individuals and defects in traditional aggregometry methods affect the market's growth and advances of platelet aggregation devices.
This research report on the Asia Pacific Platelet Aggregation Devices Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, the Asia Pacific market is predicted to hold a more significant share in the global market of platelet aggregation devices in the forecast period. Due to the increase in the incidences of chronic diseases in this region, India and China hold the largest population in the world with an increase in the elderly population as Japan has the most significant proportion of older people, which accounts for 33.1 percent of its people.
China platelet aggregation devices market has the most significant overall population with 11.9 percent of the elderly population. In comparison, the Indian platelet aggregation devices market has the second-largest population, with 6.1 percent of the elderly population. Therefore, due to the substantial rise in the number of individuals suffering from cardiovascular illnesses, these regions are expected to boost the usage of platelet aggregation devices to research platelet aggregation globally, driving the market over the projected period.
Technological advancements in the field of aggregation devices due to the rise in the trends of the platelet aggregation testing methods with the increasing adoption and market preference of automated systems among diagnostic laboratories, and the growing advantages offered by the point-of-care testing analyzer are driving the market growth for the platelet aggregation devices.
The Indian platelets aggregation devices market is expected to increase over the forecast period. Because chronic diseases are on the rise, healthcare infrastructure is improving. Therefore, government policies are supportive, and the market is growing.
Top Companies dominating the Asia Pacific Platelet Aggregation Devices Market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group and Aggredyne, Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com